Browsing: ICI

The Headline: Low dose radiation may do more than just reduce symptoms of osteoarthritis. The Study: Low dose RT is…

The Headline: Nivolumab added to ablative radiotherapy for early-stage NSCLC improves survival, at least in I-SABR.The Study: The prospective I-SABR…

Top Line: Have you ever thought much, or at all, about immunotherapy dosing and what is to be gained or…

While early salvage immunotherapy remains an attractive approach for resected high-risk melanoma, a secondary analysis of a phase 3 trial…

Headline: Mature survival analysis of CheckMate 816 confirms the addition of nivolumab to neoadjuvant chemotherapy for resectable stage IB-IIIA non-small…

Headline: Adjuvant cemiplimab improves disease free survival following adjuvant radiation in patients with resected, high risk, cutaneous squamous cell carcinoma…

Headline: Adjuvant chemoimmunotherapy is the new standard for stage III deficient mismatch repair (dMMR) colon cancer.The Study: The phase 3…

Headline: For the first time this century, a systemic therapy has moved the needle for high-risk resected head and neck…

Mirroring other disease sites, data demonstrates obesity is associated with better survival outcomes for patients receiving immune checkpoint inhibition for…